May 2, 2019 8:31am
Q1/19 financial results: Intellia Therapeutics (NTLA) and Sage Therapeutics (SAGE)
Pre-open indications: 2 BUYs, 1 SELL and 3 TRADEs
Insight is also about putting into context what is relevant to expectation
Members only. Please login.